KST(UST+9)

Your Time

Scientific Program

Updated as of May 16, 2022
It is based on the local time of Seoul, Korea. (UTC+9)

Thursday, June 16

Friday, June 17

Saturday, June 18

Thursday, June 16

Plenary Lecture 1

Date & Time	Thursday, June 16, 10:40-11:20	Place	Room A
Dynamic changes of tumor infiltrating immune cells during immunotherapies Zemin Zhang (Biomedical Pioneering Innovation Center, Peking University, China)

Plenary Lecture 2

Date & Time	Thursday, June 16, 11:20-12:00	Place	Room A
The barriers in clinical application of cancer precision medicine: Lessons from K-MASTER project Yeul Hong Kim (Korea University College of Medicine, Korea)

AOS Session 1

Session Title	Recent updates in liver cancer
Date & Time	Thursday, June 16, 13:25-15:05	Place	Room A
1)Molecular carcinogenesis of cholangiocarcinoma Bin Tean Teh (National Cancer Center Singapore, Singapore)
2)Liver transplantation for HCC Kwang-Woong Lee (Seoul National University College of Medicine, Korea)
3)Recent updates in radiotherapy for hepatocellular carcinoma Angela Giselvania (Dr Cipto Mangunkusumo Hospital, Indonesia)
4)Emerging therapeutic options for HCC and cholangiocarcinoma Tae-Yong Kim (Seoul National University College of Medicine, Korea)

Symposium 01

Session Title	Risk factors of cancer in Asia
Date & Time	Thursday, June 16, 08:40-10:20	Place	Room A
1)Human carcinogens in Asia: Information from the WHO classification of tumours Ian A Cree (World Health Organization, France)
2)Diet and cancer risk in Asia Jung Eun Lee (Seoul National University, Korea)
3)Modifiable and unmodifiable risk factors for cancer in Asia Manami Inoue (National Cancer Center, Japan)
4)Current Status and prevention of Occupational carcinogen exposure in Asia Inah Kim (Hanyang University College of Medicine, Korea)

Symposium 02

Session Title	Cancer drug discovery from proteomics
Date & Time	Thursday, June 16, 08:40-10:20	Place	Room B
1)Activation mechanism of toll-like receptors Jie-Oh Lee (POSTECH, Korea)
2)Proteomics and application in Translational research Kyunggon Kim (University of Ulsan College of Medicine, Korea)
3)Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer Adriana Franco Paes Leme (Brazilian Biosciences National Laboratory, Brazil)
4)Machine learning powered next-generation proteomics Lennart Martens (VIB and Ghent University, Belgium)

Symposium 03

Session Title	AI in cancer genomics
Date & Time	Thursday, June 16, 08:40-10:20	Place	Room D
1)Network-based machine-learning to predict drug efficacy in cancer patients Sanguk Kim (Pohang University of Science and Technology, Korea)
2)Applications of machine learning in cancer immunotherapy Jung Kyoon Choi (KAIST, Korea)
3)Harnessing synthetic lethality to advance precision cancer medicine Joo Sang Lee (Sungkyunkwan University School of Medicine, Korea)
4)Exploring phenotype patterns of breast cancer within somatic mutations Hiroshi Mamitsuka (Kyoto University, Japan)

Symposium 04

Session Title	Cancer predisposition syndrome
Date & Time	Thursday, June 16, 08:40-10:20	Place	Room E
1)Diagnosis of hereditary breast-ovarian cancer syndrome Jong-Won Kim (Sungkyunkwan University School of Medicine, Korea)
2)Surveillance in Li Fraumeni syndrome Mandy Ballinger (Garvan Institute of Medical Research, Australia)
3)Screening and management of individuals with neurofibromatosis 1 Hyery Kim (University of Ulsan College of Medicine, Korea)
4)Future genetic medicine based on HBOC phenotype and genotype Reiko Yoshida (Showa University, Japan)

Symposium 05

Session Title	Digital pathology for cancer diagnosis
Date & Time	Thursday, June 16, 13:25-15:05	Place	Room D
1)Integrating digital pathology into clinical practice Chan Kwon Jung (The Catholic University of Korea College of Medicine, Korea)
2)Digitized network for pathologic diagnosis in Japan Junya Fukuoka (Nagasaki University Graduate School of Biomedical Sciences, Japan)
3)Digital pathology project in Korea Keetaek Jang (Sungkyunkwan University School of Medicine, Korea)
4)Application of deep learning for cancer histological grading Mattias Rantalainen (Karolinska Institute, Sweden)

Symposium 06

Session Title	Liquid biopsy in precision oncology
Date & Time	Thursday, June 16, 13:25-15:05	Place	Room E
1)Review of ctDNA analysis in patients with cancer Jason D. Merker (University of North Carolina School of Medicine, USA)
2)Monitoring minimal residual disease based on ctDNA in breast cancer Wonshik Han (Seoul National University College of Medicine, Korea)
3)Liquid biopsy for advanced NSCLC - IASLC consensus statement Daniel Tan Shao Weng (National Cancer Center Singapore, Singapore)
Q&A Discussion

Symposium 07

Session Title	Image-guided cancer surgery
Date & Time	Thursday, June 16, 15:25-17:05	Place	Room B
1)Efficacy of 3-dimensional printed breast surgical guide in breast conserving surgery Beom Seok Ko (University of Ulsan College of Medicine, Korea)
2)Cutting edge technology of intraoperative near-infrared fluorescence Image during thoracic tumor surgery Hyun Koo Kim (Korea University College of Medicine, Korea)
3)Application of fluorescence imaging to liver cancer surgery Xiaoying Wang (Liver Cancer Institute, Zhongshan Hospital, Fudan University, China)
4)Utility of intraoperative fluorescence imaging in gynecologic cancer surgery Mikel Gorostidi Pulgar (Donostia Hospital, Spain)

Symposium 08

Session Title	Novel techniques in radiation oncology
Date & Time	Thursday, June 16, 15:25-17:05	Place	Room D
1)Appllication of artificial intelligence in radiation oncology Steve B. Jiang (University of Texas Southwestern Medical Center, USA)
2)Autosegmentation of target volume and normal organ delineation Yongjin(Norman) Zhu (Manteia Medical Technologies Co., China)
3)Ultra-high dose rate (FLASH) radiotherapy Hiromitsu Iwata (Nagoya Proton Therapy Center, Japan)
4)Proton minibeam technique for clinical application Young Kyung Lim (National Cancer Center, Korea)

Symposium 09

Session Title	Monitoring minimal residual disease
Date & Time	Thursday, June 16, 15:25-17:05	Place	Room E
1)MRD in hematologic oncology Anthony S. Stein (City of Hope, USA)
2)The role of Flow-, PCR- and NGS-based MRD in hematologic malignancies Myungshin Kim (The Catholic University of Korea College of Medicine, Korea)
3)Analysis of cfDNA in colon cancer Claus Lindbjerg Andersen (Aarhus University Hospital, Denmark)
4)Liquid Bx for MRD of breast cancer Han-Byoel Lee (Seoul National University College of Medicine, Korea)

Special Symposium 1

Session Title	Practice changing clinical study results in Asia (I) - Gastric Cancer
Date & Time	Thursday, June 16, 15:25-17:05	Place	Room A
1)Epidemiology of gastric cancer in Asia Manami Inoue (National Cancer Center, Japan)
2)Surgical oncology in Japan Yasuhiro Kodera (Nagoya University Graduate School of Medicine, Japan)
3)Surgical oncology in China Jiafu Ji (Peking University Cancer Hospital & Institute, China)
4)Medical oncology in the East Do-Youn Oh (Seoul National University College of Medicine, Korea)
5)Medical oncology in the West Yelena Y. Janjigian (Memorial Sloan Kettering Cancer Center, USA)

Joint Symposium 1
KCA & Korean Association of Immunologists

Session Title	Cancer immunology
Date & Time	Thursday, June 16, 13:25-15:05	Place	Room B
1)Trajectory of immune evolution in hepatocellular carcinoma Valerie Chew (SingHealth-DukeNUS, Singapore)
2)Modulation of tumor immune responses by dead cell-derived molecules Hideyuki Yanai (The University of Tokyo, Japan)
3)Towards next generation T cell engineering for Cancer Immunotherapy Chan Hyuk Kim (KAIST, Korea)
4)Disparate differentiation between naive and memory CD8 T cells during persistent antigenic stimulation Se Jin Im (Sungkyunkwan University School of Medicine, Korea)

Satellite Symposium 1 (MSD)

Date & Time	Thursday, June 16, 12:10-12:50	Place	Room A
CLEAR (KN581) - A new approval of novel combination, pembrolizumab plus lenvatinib in advanced RCC In-Ho Kim (The Catholic University of Korea College of Medicine, Korea)

Satellite Symposium 2 (Amgen)

Date & Time	Thursday, June 16, 12:10-12:50	Place	Room D
Sotorasib, the first target therapy for kras g12c mt. NSCLC Benjamin Solomon (Peter MacCallum Cancer Centre, Australia)

Oral Presentation 1

Date & Time	Thursday, June 16, 08:40-10:20	Place	Room C
1)Laparoscopic PPG versus DG for middle third EGC; Final result of multicenter RCT (KLASS-04) Hyuk-Joon Lee (Seoul National University Hospital, Korea)
2)The anatomical configuration of the splenic artery influences suprapancreatic lymph node dissection in laparoscopic gastrectomy: analysis using a 3D volume rendering program Chunchao Zhu (Shanghai Jiao Tong University, China)
3)Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer Byung Min Lee (The Catholic University of Korea Uljeongbu St. Mary's Hospital, Korea)
4)Thoracic cavity-to-cage ratio is a predictor of technical difficulties in minimally invasive esophagectomy Tomoki Abe (Graduate School of Medicine, Kobe University, Japan)
5)Association between G8 score and overall survival in the patients with esophageal cancer treated with definitive chemoradiotherapy Ryo Narukami (Kyoto University, Japan)
6)Chemotherapy-induced reprogramming of cancer-associated fibroblasts promotes gastric cancer progression and resistance to chemotherapy Inhye Ham (Ajou University Hospital, Korea)
7)Prediction model for screening patients at risk of malnutrition after gastric cancer surgery Ji-Hyeon Park (Gachon University Gil Medical Center, Korea)
8)Comprehensive analysis of alternative splicing in gastric cancer identifies epithelial-mesenchymal transition subtypes associated with survival Yun-Suhk Suh (Seoul National University Bundang Hospital, Korea)
9)Genomic and evolutionary characteristics of gastric cancer by metastatic routes Yoon Young Choi (CHA University School of Medicine, Korea)
10)Activation of JAK-STAT1 signaling pathway is an early response to helicobacter pylori infection and contributes to immune escape and gastric carcinogenesis Xue Li (Peking University Cancer Hospital, China)

Oral Presentation 2

Date & Time	Thursday, June 16, 13:25-15:05	Place	Room C
1)Secondary malignancies in cancer survivors and the susceptibility to hereditary multiple cancer syndrome: A Korean nationwide population-based study Yoon Young Choi (CHA University School of Medicine, Korea)
2)Universal genetic testing identifies more hereditary cancer syndrome patients than guideline directed targeted testing: A multi-center prospective study May Chow (Invitae, Singapore)
3)Associations between patterns of physical activity and incidence of cancer among obese adults in Korean: Results from health examinees-G study Jaesung Choi (Seoul National University Medical Research Center, Korea)
4)Risk of cancer development and mortality in women with prediabetes and diabetes: A population-based cohort study Thi Xuan Mai Tran (Hanyang University College of Medicine, Korea)
5)Effect of Helicobacter pylori eradication on blood metabolite fingerprints and their interactions on the progression of gastric lesions Wen-Qing Li (Peking University Cancer Hospital, China)
6)Integration of DNA methylation data of TCGA cancer and KoGES normal samples: Survival rate and chronic disease by clustering pattern Jeong-An Gim (Korea University Guro Hospital, Korea)
7)Exposure to high serum levels of IL-6 is associated with increased lifetime risk of cancer Yoo Hyung Kim (Seoul National University Hospital, Korea)
8)Healthcare utilization of cancer patients during the COVID-19 pandemic Seung Hee Seo (Seoul National University Hospital, Korea)

Oral Presentation 3

Date & Time	Thursday, June 16, 15:25-17:05	Place	Room C
1)Long-term survival analysis from colorectal cancer associated with Microsatellite instability and tumor-infiltrating lymphocytes and Crohn's-like lymphoid reaction Chul Seung Lee (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
2)Inhibition of 15-prostaglandin dehydrogenase(15-PGDH) enhances colon cancer metastasis by upregulation of Epithelial to mesenchymal transition(EMT)-associated genes via increasing PGE2 level Ki Beom Bae (Inje University Busan Paik Hospital, Korea)
3)A microRNA panel in Normal tissue Adjacent to the Tumor (NAT) is a predictive biomarker for colorectal cancer recurrence Lui Ng (The University of Hong Kong, Hong Kong, China)
4)Circulating tumor DNA mutations in progressive gastrointestinal stromal tumors identify drug resistance biomarkers and uncover potential therapeutic strategies Tun Kiat Ko (National Cancer Centre Singapore, Singapore)
5)Post-operative genomic/epigenomic signatures of circulating tumor DNA and recurrence in colorectal cancer: COSMOS-CRC-01 Nobuhisa Matsuhashi (Gifu University Hospital, Japan)
6)Association of preoperative dietary habits and exercise with postoperative complications in patients who underwent elective surgery for colorectal cancer: A prospective cohort study Hyo Jun Kim (Seoul National University Hospital, Korea)
7)The watch‑and‑wait strategy versus surgical resection for rectal cancer patients with a good response (≤ycT2) after neoadjuvant chemoradiotherapy Chungyeop Lee (Pohang Naval Hospital, Korea)
8)Comparison of chemoradiation therapy vs. adjuvant chemotherapy alone in patients with extremely low rectal cancer requiring abdominoperineal resection Nahyeon Park (Soon Chun Hyang University Bucheon Hospital, Korea)
9)The role of adjuvant radiotherapy in node-negative parotid gland cancer Jung Bin Park (Seoul National University Hospital, Korea)

Friday, June 17

Plenary Lecture 3

Date & Time	Friday, June 17, 10:40-11:20	Place	Room A
Pancreas Cancer - Improving outcomes through molecular diagnostics and therapeutics Jeffrey A. Drebin (Memorial Sloan Kettering Cancer Center, USA)

Jin-Pok Kim Memorial Lecture

Date & Time	Friday, June 17, 11:20-12:00	Place	Room A
Clonal evolution in normal tissues Seishi Ogawa (Kyoto University Graduate School of Medicine, Japan)

AOS Session 2

Session Title	Future leadership of AOS
Date & Time	Friday, June 17, 13:25-15:05	Place	Room A
1)Yeul Hong Kim (Korea University Medical College, Korea)
2)Sanjeev Misra (All India Institute of Medical Sciences, Jodhpur, India)
3)Ying Wang (China Anti-Cancer Association, China)
4)Kazuhiro Yoshida (Gifu University, Graduate School of Medicine, Japan)
Panelists Agus Rizal Ardy Hariandy Hamid (Indonesian Urology Oncology Society, Indonesia) Hsuen Elaine Lim (National Cancer Centre Singapore, Singapore) Ekaphop Sirachainan (Ramathibodi Hospital, Mahidol University, Thailand) Dang Huy Quoc Thinh (Ho Chi Minh City Oncology Hospital, Vietnam) Zeba Aziz (Hameed Latif Hospital, Pakistan) Gloria R. Cristal-Luna (St. Luke’s Medical Center Quezon City, Philippines)

Symposium 10

Session Title	Survivorship in cancer care
Date & Time	Friday, June 17, 08:40-10:20	Place	Room A
1)Unique needs and concerns of childhood cancer survivors Yasushi Ishida (Ehime Prefectural Central Hospital, Japan)
2)Development of survivorship care coordination model：Experiences in Japan Miyako Tsuchiya (Musashino University, Japan)
3)Integrating psycho-oncology to improve mental health for cancer survivors Seockhoon Chung (University of Ulsan College of Medicine, Korea)
4)The effect of exercise on the QoL and survival in cancer survivors Justin Y. Jeon (Yonsei University, Korea)

Symposium 11

Session Title	Novel targeted therapy and resistance
Date & Time	Friday, June 17, 08:40-10:20	Place	Room B
1)Novel targeted therapy and resistance in EGFR-mutant lung cancer Ji-Youn Han (National Cancer Center, Korea)
2)HER2-targeted therapy Shaheenah Dawood (Mohammed Bin Rashid University of Medicine and Health Sciences, UAE)
3)Anti-angiogenetic therapy Masafumi Ikeda (National Cancer Center Hospital East, Japan)
4)Potential role of targeted agents in IO-refractory gastric cancer Jeeyun Lee (Sungkyunkwan University School of Medicine, Korea)

Symposium 12

Session Title	Current consensus of treatment for oligometastasis
Date & Time	Friday, June 17, 08:40-10:20	Place	Room D
1)Oligometastases: What have we learned? David Anthony Palma (London Health Sciences Centre, Canada)
2)Korean radiation oncologists' perspective Chai Hong Rim (Korea University College of Medicine, Korea)
3)Korean medical oncologists' perspective: What is the definition of ‘Oligo’? Dae Ho Lee (University of Ulsan College of Medicine, Korea)
4)Management of oligometastasis from colorectal cancer Jong-Hoon Lee (The Catholic University of Korea College of Medicine, Korea)
5)Locally aggressive hypofractionated RT(SBRT) for Oligometastatic NSCLC Hak Choy (University of Texas Southwestern Medical Center, USA)

Symposium 13

Session Title	Novel immunotherapy and resistance
Date & Time	Friday, June 17, 13:25-15:05	Place	Room B
1)Immunologic resistance mechanisms of cancer immunotherapy Eui-Cheol Shin (KAIST, Korea)
2)Immunotherapy resistance and its overcoming strategy in lung cancer Se-Hoon Lee (Sungkyunkwan University School of Medicine, Korea)
3)Immunotherapy resistance and its overcoming strategy in gastric cancer Narikazu Boku (IMSUT Hospital, Institute of Medical Science, University of Tokyo, Japan)
4)Immunotherapy combination therapy for immune checkpoint inhibitor-resistant cancer Hussein A. Tawbi (University of Texas MD Anderson Cancer Center, USA)

Symposium 14

Session Title	DNA damage response in cancer
Date & Time	Friday, June 17, 15:25-17:05	Place	Room B
1)Targeting the DNA damage response pathway in advanced cancers David SP Tan (National University of Singapore, Singapore)
2)Mechanisms of resistance to PARP inhibitors in advanced cancers Kyung-Hun Lee (Seoul National University College of Medicine, Korea)
3)PARP inhibition in future Nicola Jane Curtin (Newcastle University, UK)
Q&A Discussion

Symposium 15

Session Title	암관련학회협의체 심포지엄: National Cancer Guideline
Date & Time	Friday, June 17, 15:25-17:05	Place	Room C
1)국가암진료 가이드라인 사업 소개 김열 (국립암센터)
2)국가암진료 가이드라인 개발 방법론 김수영 (한림의대)
3)사업비 개괄 및 객관적 집행 방안 곽호신 (국립암센터)
4)참여학회의 기대와 보완점 - 대한대장항문학회 엄준원 (고려의대)
5)참여학회의 기대와 보완점 - 대한갑상선학회 이은경 (국립암센터)
패널토론 한상균 (보건복지부), 김시영 (건강보험심사평가원), 김현정 (고려대 근거중심의학연구소), 김병기 (성균관의대)

Symposium 16

Session Title	Palliative care in Asian countries
Date & Time	Friday, June 17, 15:25-17:05	Place	Room E
1)Past, present, future of palliative care in Japan Yusuke Hiratsuka (Takeda General Hospital, Japan)
2)Past, present, future of palliative care in Taiwan Shao-Yi Cheng (College of Medicine and Hospital, National Taiwan University, Taiwan)
3)Recent efforts to expand horizons of palliative care in Korea Yu Jung Kim (Seoul National University College of Medicine, Korea)
4)Life-sustaining treatment states in Korean cancer patients after enforcement of act on decisions on life-sustaining treatment Jung Hye Kwon (Chungnam National University College of Medicine, Korea)

Special Symposium 2

Session Title	Practice changing clinical study results in Asia (II) – Lung Cancer
Date & Time	Friday, June 17, 15:25-17:05	Place	Room A
1)Lung cancer screening Pan-Chyr Yang (National Taiwan University, Taiwan)
2)Anatomical extent of lung parenchyma in the radical resection for lung cancer: Does segmentectomy surrogate lobectomy for small-sized, peripheral lung cancer? Hisao Asamura (Keio University School of Medicine, Japan)
3)Radiation treatment for metastatic EGFR-mutant non-small cell lung cancer Zhengfei Zhu (Fudan University Shanghai Cancer Center, China)
4)Practice changing clinical study results in Asia – Medical treatment for lung cancer Myung-Ju Ahn (Sungkyunkwan University School of Medicine, Korea)

Joint Symposium 2
KCA & Korea Genome Organization

Session Title	Deeper understanding of cancer genomes
Date & Time	Friday, June 17, 13:25-15:05	Place	Room D
1)Landscape and function of multiple mutations within individual oncogenes Keisuke Kataoka (Keio University School of Medicine, Japan)
2)Extrachromosomal DNA in multiple cancers Hoon Kim (Sungkyunkwan University, Korea)
3)Recent insights from single-cell-omics studies in colorectal cancer Iain Tan (National Cancer Centre Singapore, Singapore)
4)Mutation pairs with evolutionary dependency in cancer genomes Tae-Min Kim (The Catholic University of Korea College of Medicine, Korea)

Joint Symposium 3
KCA & Korean Society for Neuro-Oncology

Session Title	Biology and treatment of CNS metastases
Date & Time	Friday, June 17, 13:25-15:05	Place	Room E
1)Molecular biology of CNS metastases Ho-Shin Gwak (National Cancer Center, Korea)
2)Targeted therapy for advanced cancer with CNS metastases Hye Ryun Kim (Yonsei University College of Medicine, Korea)
3)Local treatment for CNS metastases in the targeted therapy era Young Zoon Kim (Sungkyunkwan University School of Medicine, Korea)
4)RANO response criteria for brain and leptomeningeal metastases Seung Hong Choi (Seoul National University College of Medicine, Korea)

Joint Symposium 4
KCA & Korean Society of Gynecologic Oncology

Session Title	Recent strategies for treating cervical cancer
Date & Time	Friday, June 17, 15:25-17:05	Place	Room D
1)Evolution of cervical cancer treatment with the emergence of immune checkpoint inhibitors Masahiro Kagabu (Iwate Medical University, Japan)
2)2020 WHO classification of cervical adenocarcinoma Cheol Lee (Seoul National University College of Medicine, Korea)
3)Recent advance of radiotherapy for cervical cancer Sezin Yuce Sari (Hacettepe University Medical School, Turkey)
4)DNA vaccine as a novel treatment for cervical cancer in future Youn Jin Choi (The Catholic University of Korea College of Medicine, Korea)

Satellite Symposium 3 (Servier)

Date & Time	Friday, June 17, 11:20-11:40	Place	Room D
Liposomal irinotecan and innovative drug delivery system in pancreatic cancer Kyu-Pyo Kim (University of Ulsan College of Medicine, Korea)

Satellite Symposium 4 (Pfizer)

Date & Time	Friday, June 17, 12:10-12:50	Place	Room A
Maximizing clinical benefit with CDK4/6 inhibitors: Long-term efficacy & safety of palbociclib Kyung-Hun Lee (Seoul National University College of Medicine, Korea)

Satellite Symposium 5 (AstraZeneca)

Date & Time	Friday, June 17, 12:10-12:50	Place	Room D
Today & Tomorrow of EGFRm NSCLC: From early to advanced stage Sun Min Lim (Yonsei University College of Medicine, Korea)

Outstanding Abstract Session

Date & Time	Friday, June 17, 08:40-09:40	Place	Room E
1)Adoptive transfer of T cells targeting shared p53 neoantigens to treat human solid cancers Sanghyun Kim (National Cancer Institute, USA)
2)Oncologic outcome between abdominoperineal resection and sphincter preservation surgery for low rectal cancer; A long-term survival analysis of prospective, multicenter, cohort ASPIRE study Hong-min Ahn (Seoul National University Bundang Hospital, Korea)
3)Immunogenic responses of ChAdOx1nCoV-19 and CoronaVac vaccines in cancer patients receiving chemotherapy and non-chemotherapy treatment Chayanee Samdaengpan (Chulabhorn Royal Academy, Thailand)

Oral Presentation 4

Date & Time	Friday, June 17, 08:40-10:20	Place	Room C
1)Depleting tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor immune response Jeong A Park (Inha University Hospital, Korea)
2)Anti-mesothelin human CAR-T cells producing IL-7 and CCL19 enhance antitumor efficacy against solid cancer in orthotopic and PDX mouse models Shunsuke Goto (Kyushu University, Graduate School of Medical Sciences, Japan)
3)Therapeutic potential of anti-vascular endothelial growth factor receptor 2 therapy for M2 tumor-associated macrophages in colorectal cancer Koji Kono (Fukushima Medical University, Japan)
4)Highly selective inhibitor for AXL overcomes stroma-induced resistance to chemotherapeutic agents through downregulation of ABCG1 in gastric cancer Taehoon Kim (Ajou University School of Medicine, Korea)
5)Targeting metabolic variance and plasticity as a novel therapeutic strategy for triple-negative breast cancer Jiyoung Lee (George Washington University, USA)
6)Established patient-derived organoids using ascites fluid or pleural effusion in cancer patients Yebeen Yu (National Cancer Center, Korea)
7)Disc-type 3D in vitro cancer modeling system for spatiotemporal visualization of cell-cell interaction Haruko Takahashi (Hiroshima University, Japan)
8)High-throughput functional evaluation of human cancer-associated mutations using base editors Seungho Lee (Yonsei University College of Medicine, Korea)

Oral Presentation 5

Date & Time	Friday, June 17, 13:25-15:05	Place	Room C
1)Novel NSDHL inhibitor (Compound 9) induces cytotoxic activity and G0/G1 arrest in breast cancer cells So-Hyun Yoon (Seoul National University, Korea)
2)Prediction of platinum-based chemotherapy resistance for epithelial ovarian cancer Heekyoung Song (The Catholic University of Korea Incheon St. Mary's Hospital, Korea)
3)The clinical impact of age-specific distribution combination patterns of cytology & high-risk HPV status in the background of cervical intraepithelial neoplasia grade 3 or greater Mie Sakai (Shiga General Hospital, Japan)
4)Homologous recombination deficiency in pancreas ductal adenocarcinoma and treatment outcome: A multicenter real-world experience Yung-Yeh Su (National Health Research Institutes, Taiwan)
5)An integrative single-cell transcriptome analysis reveals transitional cancer cell state associated with poor prognosis in pancreatic cancer Galam Leem (Severance Hospital, Korea)
6)Spatial transcriptomics reveals perineural invasion signature showing clinically relevant therapeutic resistance in the patient with advanced gallbladder cancer Sung Hwan Lee (CHA University School of Medicine, Korea)
7)CADM1 and SPC25 gene mutations in lung cancer patients with idiopathic pulmonary fibrosis Aya Fukuizumi (Nippon Medical School, Japan)
8)Patient-derived cells (PDCs) recapitulate tumor heterogeneity (TH) to target therapy in advanced lung cancer patients Youngjoo Lee (National Cancer Center, Korea)
9)Efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis Sora Kang (Chungnam National University Hospital, Korea)
10)Overall survival in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib: Results from the phase I/II study Ji-Youn Han (National Cancer Center, Korea)

Saturday, June 18

Symposium 17

Session Title	New frontiers in cancer drug development
Date & Time	Saturday, June 18, 08:40-10:20	Place	Room A
1)Modifiers of cancer immunity Junho Chung (Seoul National University College of Medicine, Korea)
2)Novel discovery of antibody-drug conjugates for advanced cancers Kaku Saito (Daiichi Sankyo, Inc, USA)
3)Mapping the degradable kinome using PROTACs Taebo Sim (Yonsei University College of Medicine, Korea)
Q&A Discussion

Symposium 18

Session Title	Tissue-agnostic anticancer drugs: A paradigm shift in leveraging cancer biology for precision medicine
Date & Time	Saturday, June 18, 10:40-12:20	Place	Room A
1)Update of NTRK inhibitors for NTRK fusion-positive tumors David S. Hong (The University of Texas MD Anderson Cancer Center, USA)
2)Pembrolizumab for MSI-H or dMMR tumors Do-Youn Oh (Seoul National University College of Medicine, Korea)
3)HER2 targeted agents in breast, gut, and beyond Kyung Hae Jung (University of Ulsan College of Medicine, Korea)
4)Novel clinical trial designs for tissue-agnostic drug development Jee Hyun Kim (Seoul National University College of Medicine, Korea)

Joint Symposium 5
KCA & Asian Oncology Nursing Society

Session Title	Collaborative modalities for better cancer care
Date & Time	Saturday, June 18, 08:40-10:20	Place	Room B
1)Addressing cancer care disparities through collaboration: opportunities and future directions Winnie K.W.So (The Chinese University of Hong Kong, Hong Kong, China)
2)Care of cancer survivors in a multi-disciplinary clinic Janette Vardy (University of Sydney, Australia)
3)Networking development and information sharing among Asian oncology nurses Eunyoung Suh (Seoul National University College of Nursing, Korea)
4)Integration of supportive palliative care through the overall trajectory of cancer care Su-Jin Koh (University of Ulsan College of Medicine, Korea)

Joint Symposium 6
KCA & Korean GIST Study Group

Session Title	Novel therapies in GIST
Date & Time	Saturday, June 18, 10:40-12:20	Place	Room B
1)Endoscopic resection of gastric GIST Hwoon-Yong Jung (University of Ulsan College of Medicine, Korea)
2)Advance in surgical resection of GIST Toshiro Nishida (National Cancer Center Hospital, Japan)
3)Chemotherapy Li-Tzong Chen (Kaohsiung Medical University, Taiwan)
4)Molecular pathology of GISTs for precision medicine Hye Seung Lee (Seoul National University College of Medicine, Korea)

Joint Symposium 7
KCA & Korean Spine Oncology Research Society

Session Title	Management of spinal bone metastases
Date & Time	Saturday, June 18, 10:40-12:20	Place	Room C
1)Algorithm based approach for spinal metastasis Fon-Yih Tsuang (National Taiwan University Hospital, Taiwan)
2)Total en block spondylectomy and immunotherapy for spinal metastasis Kota Watanabe (Keio University School of Medicine, Japan)
3)Total en block spondylectomy- Setting resection margin based on tumor location Arjun Sahgal (Odette Cancer Centre, University of Toronto, Canada)
4)Role of chemotherapy for spinal bone metastasis Tae-Yong Kim (Seoul National University College of Medicine, Korea)